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Protocol
AbstrACt
Introduction Hip arthroscopy has become a standard 
procedure in the treatment of hip joint pain not related to 
osteoarthritis or dysplasia in the young and active patient. 
There has been increasing focus on the contribution of 
the hip capsule to function and on stability following hip 
arthroscopy. It has been suggested that capsular closure 
after hip arthroscopy may prevent microinstability and 
macroinstability of the hip joint and reduce revision rate. 
However, it remains unknown whether capsular closure 
should be performed as a standard procedure when 
performing hip arthroscopies, especially in patients without 
additional risk factors for instability such as hypermobility 
or dysplasia of the hip. We hypothesised that capsular 
closure will lead to a superior outcome in hip arthroscopy 
for femoroacetabular impingement syndrome (FAIS) 
compared with non-capsular closure.
Methods and analysis In this randomised controlled, 
multicentre trial, 200 patients scheduled for hip arthroscopy 
for FAIS will be cluster randomised into one of two groups 
(group I: hip arthroscopy without capsular closure, group II: 
hip arthroscopy combined with capsular closure). Inclusion 
criteria are: age between 18 years and 50 years and FAIS 
according to the Warwick agreement. Exclusion criteria are: 
previous hip surgery in either hip, previous conditions of 
Legg-Calvé-Perthes or slipped capital femoral epiphysis, 
malignant disease, recent hip or pelvic fractures, arthritis, 
Ehlers-Danlos or Marfan disease, recent (within 6 weeks) 
application of intra-articular corticosteroids, language 
problems of any kind, and radiological signs of osteoarthritis, 
acetabular dysplasia or acetabular retroversion. Surgery will 
be performed in Denmark at four centres by four surgeons, 
all performing an interportal capsulotomy and closure with at 
least two absorbable sutures. Patients in both groups, who are 
blinded for the intervention, will receive the same standardised 
rehabilitation programme. As primary outcome scores, HAGOS 
(sport) will be used with HAGOS (symptoms, pain, function 
in daily living, participation in physical activities and hip and/
or groin-related quality of life), Hip Sports Activity Scale, short 
validated version of the International Hip Outcome Tool, EQ-5D, 
Visual Analogue Scale for pain, complications and reoperation 
rate as secondary outcome tools. Using HAGOS (sport) as 
primary outcome parameter the power analysis required a 
minimum of 84 individuals per group. Together with a clinical 
examination performed by the patient's surgeon 1 year after 
surgery, patient reported outcome measures will be completed 
preoperatively, as well as at 3 months, 1 year, 2 years and 
5 years postoperatively. In addition, adverse effects will be 
recorded.
Ethics and dissemination The study is approved by 
the Central Denmark Region Committee on Biomedical 
research ethics. The results of this study will be presented 
at national and international congresses and published in 
peer-reviewed journals.
trial registration number NCT03158454; Pre-results.
IntroduCtIon 
In recent years hip arthroscopy has 
become the method of choice in treating 
strengths and limitations of this study
 ► This is a randomised, blinded study with self-
reported outcomes as end points.
 ► It is a nationwide study covering the vast majority 
of all patients undergoing hip arthroscopy for 
femoroacetabular    impingement syndrome in 
Denmark; it includes consecutive patients.
 ► Due to the multicentre design, surgery and 
rehabilitation may be influenced by local tradition. 
This is compensated for by the randomised design 
and efforts to harmonise surgical technique and 
rehabilitation.
 ► Long-term complications such  as degenerative 
cartilage changes due to microinstability caused by 
capsulotomy may not be possible to demonstrate 
within the 5-year follow-up.
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intra-articular pathologies of the hip not related to 
osteoarthritis or developmental pathologies such as hip 
dysplasia or acetabular retroversion. Especially femoro-
acetabular impingement syndrome (FAIS) with intra-ar-
ticular pathologies such as cam morphology, pincer type 
morphology articular cartilage and/or labral lesions 
are considered a primary indication for arthroscopic 
surgery. In contrast to (mini) open procedures or even 
open dislocation of the hip joint, hip arthroscopy allows 
direct visualisation and treatment of the pathology 
combined with minimal soft tissue trauma and fast post-
operative mobilisation.1 2 The arthroscopic technique of 
hip arthroscopy has evolved over recent years, as has the 
understanding of biomechanics of the hip joint. Apart 
from acetabular coverage, the acetabular labrum and 
the hip capsule have been identified as major contribu-
tors to hip joint stability.3–7 
The hip joint has both dynamic and static stabilisers. 
The hip capsule consists of four major structures: the 
iliofemoral, pubofemoral and ischiofemoral ligaments 
and the zona orbicularis, where the iliofemoral ligament 
is of major importance due to its role in arthroscopic 
surgery. It is the strongest of the abovementioned struc-
tures and is crucial in resisting external rotation, ante-
rior translation, extension and hip dislocation.5 8 In hip 
arthroscopy an interportal capsulotomy is usually used 
to enter the hip joint, putting the hip capsule, and here 
especially, the iliofemoral ligament, at risk. In a cadaver 
study Bayne et al could show increased anterior transla-
tion and neutral rotation as well as increased posterior 
translation with the hip in flexion, when capsulotomy had 
been performed.9
Although gross instability or even traumatic hip dislo-
cation after hip arthroscopy are rare complications,10 
postoperative microinstability due to insufficient capsular 
closure is believed to be a potential cause for an inferior 
functional outcome after hip arthroscopy.11 Furthermore 
it has been stated that capsular closure may lead to a more 
predictable and reliable hip function with a lower rate of 
revision surgery.8 11–13
It has been postulated that capsular closure after hip 
arthroscopy leads to re-establishment of anatomical 
joint stability,7 however, the positive effects on the clin-
ical outcome following hip arthroscopy are yet to be 
proven. In clinical studies comparing the outcome of 
patients with borderline dysplasia with non-dysplastic 
patients with FAIS, there seems to be a favourable 
outcome when capsular closure is performed.14 15 When 
comparing capsular closure with non-closure retrospec-
tively, Domb et al reported no significant differences in 
clinical outcomes.16 However, Domb et al concluded that 
capsule closure did not have any negative effect on the 
outcome either, keeping in mind that the conclusions 
drawn in their study were limited due to significant 
differences in age, body mass index, gender, preop-
erative patient reported outcome score (PROs) and 
degree of chondral damage in the groups compared. 
When comparing different types of capsular closures, 
complete closure seems to be superior to partial 
closure. In a prospective cohort study Frank et al17 
found superior outcome at 6 months, 1 year, 2 years and 
5 years after hip arthroscopy for FAIS when comparing 
patients with full closure of a T-capsulotomy with a 
matched group of patients, where the interportal part 
of the T-capsulotomy was left unrepaired. In a biome-
chanical study analysing the strength of the capsule 
closure and the number of sutures needed Chahla et al 
reported no significant difference whether two or three 
No. 2 Vicryl sutures (Ethicon) were used, when closing 
an interportal capsulotomy.18
Gupta et al19 reported preferences in surgical proce-
dures by 27 high-volume orthopaedic surgeons special-
ising in hip arthroscopy (>50 hip arthroscopies per year). 
Although all performed capsulotomy routinely, the 
results showed a huge variability in how and when closure 
of the hip capsule was performed. Three surgeons closed 
the capsule every time. Ten and 11 surgeons, respectively, 
closed the capsule in more than 50% and less than 50% 
of the times. Three surgeons never closed the capsule.
According to the Danish Hip Arthroscopy Registry 
(DHAR), a national database with 14 participating centres, 
which was established in 2012 and with data from 3541 proce-
dures (8 October 2016), capsular closure was performed 
in only 10% of all hip arthroscopies.20 Further analysis of 
the data from DHAR showed that patients who under-
went capsular closure had superior results in postoperative 
outcome scores (hip and groin outcome score (HAGOS), 
Hip Sports Activity Scale (HSAS), Visual  Analogue Scale 
(VAS) and EQ-5D a standardised instrument of measuring 
generic health status) at 2-year follow-up when compared 
with a matched FAIS cohort (cohorts were matched 
according to age, gender, lateral centre edge and alpha 
angles).21 Although capsule closure was only performed 
routinely by one single surgeon, these findings could indi-
cate a positive effect on clinical outcome of capsule closure 
which needs further investigation in randomised controlled 
trials. In general, capsule closure is considered more tech-
nically challenging with an increased risk of iatrogenic inju-
ries to, for example, femoral cartilage or a reduced external 
rotation due to an overtightening of the capsule;22 however, 
there is no scientific evidence that capsule closure leads to 
inferior outcome or other adverse effects.23
AIM
The aim of this multicentre randomised controlled trial 
is to evaluate the effect of capsular closure in relation to 
postoperative outcomes and revision rates for patients 
undergoing hip arthroscopy for FAIS.
HypotHEsIs
We hypothesise that patients treated with hip arthroscopy 
for FAIS would have significantly improved subjective and 
clinical outcomes if capsular closure is performed.
 o
n
 6 M
arch 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-019176 on 10 February 2018. Downloaded from 
 3Dippmann C, et al. BMJ Open 2018;8:e019176. doi:10.1136/bmjopen-2017-019176
Open Access
dEsIgn
A prospective, multicentre (n=4) study with a randomised 
controlled two-arm design is being conducted at four 
Danish hospitals. Two hundred participants scheduled 
for hip arthroscopy, due to FAIS, are randomly assigned 
in a 1:1 ratio to hip arthroscopy without (group I) or with 
(group II) capsular closure. The inclusion process started 
in June 2017 is expected to last approximately 2 years.
MAtErIAl
patients
All patients referred to the four participating orthopaedic 
departments in Denmark for hip arthroscopy and who 
meet the inclusion criteria, will be asked to participate in 
this study. In order to show a minimal clinically important 
difference (MCID) we estimated a 10-point increase in 
the HAGOS Sport subscale as a relevant MCID.24 When 
the power is set at 0.9 and at an alpha value of 5%, the 
number of patients in each group should be 84 (SD=20). 
To allow for possible dropouts the total estimated sample 
size of patients included in each group is n=100.
Inclusion criteria
The participating patients have to be between 18 years 
and 50 years old and need to have radiological and clin-
ical signs of FAIS as described by Griffin et al.25 Symptoms 
of FAIS are: reported pain in the hip or groin area with 
painful active and/or passive range of motions as well as 
patient history of clicking, catching, locking, stiffness, 
restricted range of motion or giving way. Clinical find-
ings of FAIS are defined by a positive reproduction of 
the patient's usual pain from the hip joint during hip 
impingement test such as the Flexion Adduction Internal 
Rotation (FADIR) test normally with limited range of 
motion, typically internal rotation in flexion.
Radiological findings of FAIS are defined here as an 
alpha angle >55° (cam-type morphology) in cross-table 
axial radiograph and a positive cross-over sign and/
or a centre edge angle (CE angle) >39° (pincer-type 
morphology) on a standardised anteroposterior (AP) 
pelvic X-ray.26 Since, so far, there is no scientific evidence 
of superiority in treating FAIS non-operatively, struc-
tured exercise prior to hip arthroscopy has not been a 
requirement for inclusion to this study. However, patients 
suspected for an accompanying extra-articular pain 
generator will be referred to structured physiotherapy 
for at least 3 months before being considered for surgical 
treatment.
Exclusion criteria
Patients are excluded from the study when one of the 
following features apply (table 1): previous hip surgery 
in either hip, previous conditions of Legg-Calvé-Perthes 
or slipped capital femoral epiphysis, malignant disease, 
recent hip or pelvic fractures, arthritis, Ehlers-Danlos or 
Marfan disease, recent (within 6 weeks) application of 
intra-articular corticosteroids, for example, methylpred-
nisolone acetate (Depo-Medrol), language problems of 
any kind, and radiological signs of osteoarthritis, defined 
by a lateral joint space width <3 mm or grade >1 according 
to Tönnis classification; furthermore, radiological signs of 
acetabular dysplasia, defined by a CE angle <25 degrees 
(modified Wiberg,27), or acetabular retroversion, defined 
by a positive cross-over sign in combination with a positive 
posterior wall sign and a positive ischial spine sign when 
applying standardised AP pelvic X-rays.24
patient involvement
Patients were not directly involved in the design of this 
study as the intervention in this study is not considered 
to change the postoperative regime or the patient’s 
Table 1 Inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria
 ► Age between 18 years and 50 years
 ► Femoroacetabular impingement syndrome 
according to the agreement paper from Warwick25
 ► Indication for surgery according to the examining 
surgeon
 ► Previous hip surgery in either hip
 ►Malignant disease
 ► Recent hip or pelvic fractures
 ► Ehlers-Danlos and Marfan syndromes
 ► Arthritic disease
 ► Hip joint dysplasia, defined by both centre edge (CE) angles <250 and 
Acetabular Index angle >100
 ► Acetabular retroversion, defined by the combined presence of cross-
over sign in the lower two-third of the joint, posterior wall sign and 
prominent ischial spine sign
 ► Osteoarthrosis grade ≥2 according to Tönnis classification
 ► Joint space width <3 mm at the lateral part of the sourcil on 
anteroposterior pelvis X-ray
 ► Legg-Calvé-Perthes
 ► Slipped capital femoral epiphysis
 ► Recent (within 6 weeks) medical treatment with corticosteroids
 ► Language problems of any kind
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direct perception of the preoperative and postoperative 
processes. As the enrolment in a clinical trial may influ-
ence the patient’s view of the clinical work or even feel 
like a burden, the patients will be interviewed randomly 
to identify adverse effects.
Imaging
Prior to surgery, an AP pelvis radiograph and a cross-table 
axial radiograph of the index hip will be taken and eval-
uated according to the criteria defined by Tannast et al.26 
Patients with radiological signs of osteoarthritis, develop-
mental dysplasia of the hip or acetabular retroversion will 
be excluded from the study.
Clinical examination
All patients will undergo a complete physical examina-
tion with passive and active range of motion of the hip, 
as well as testing for extra-articular and intra-articular 
pain generators such as psoas tendon pain, iliotibial band 
pain, adductor tendon pain or gluteal pain. Extra-artic-
ular pain generators will be reported. The patients will 
have the flexion, abduction and external rotation test and 
the anterior impingement test performed, as described 
by Ratzlaff et al.28 The test is positive when the known 
pain is experienced in the upper/inner thigh or groin. 
To support the radiological and clinical findings an ultra-
sound-guided, diagnostic intra-articular injection with 
anaesthetics may be performed as this has been shown to 
be a sensitive tool in identifying intra-articular pain.29 30
outcome parameters
The patient's outcome will be evaluated using patient-re-
lated outcome measurements preoperatively and at 3 
months, 1 year, 2 years and 5 years after surgery. The 
primary outcome score is the HAGOS subscale Sport 
while HAGOS with its subscales Symptoms, Pain, Func-
tion in daily living, participation in physical activities and 
hip and/or groin-related quality of life (QOL), as well 
as the International Hip Outcome Tool (iHOT), HSAS, 
VAS and Numerical Rating Scale (NRS) will be secondary 
outcome scores. HAGOS consists of six subscales, which 
can be evaluated separately.31 32 HAGOS is a question-
naire (37 questions in total) aimed at young to middle-
aged adults undergoing hip arthroscopy or non-surgical 
treatment for patients presenting with groin pain. In this 
study the short validated version of iHOT (iHOT12) is 
also used for initial patient assessment and as postop-
erative follow-up. The iHOT12 is validated to measure 
health-related QOL and to identify changes after treat-
ment in young and active patients with hip disorders. 
The total score is calculated as a simple mean of these 
12-item responses ranging from 0 to 100, with a higher 
score representing a better overall QOL Score.33 EQ-5D 
is a widely used generic health-related QOL measure.34 
HSAS is also used and recommended as a reliable and 
valid activity measurement useful for patients with FAIS.35 
Pain levels are measured using VAS and NRS pain scores 
at rest and after 15 min of walking on a flat surface. The 
timeline of the preoperative and postoperative follow-up 
examinations can be seen in table 2.
Information and patient approval
The patient will, after the initial clinical examination in 
the outpatient clinic when indications for surgical treat-
ment of FAIS are confirmed and the patient is assigned 
for hip arthroscopy, be informed about the project and 
the possibility to participate. Written information will be 
given, and the patient—if he/she has possible interest 
in participating in the study—will be included or if he 
wishes, will be invited to a meeting in the outpatient clinic 
under undisturbed circumstances for further informa-
tion. The patient may bring an assessor for this meeting. 
When the patient has had the time for considering partic-
ipation and if he wishes to participate, informed consent 
is signed by the patient and the surgeon in accordance 
with the Declaration of Helsinki II.
randomisation process
Assignment into groups will be performed using sequen-
tially numbered opaque sealed envelopes. Each centre 
will be given 50 of these cluster-randomised envelopes, 
Table 2 The timeline of the study and the preoperative and postoperative follow-up
Follow-up Preoperative Perioperative 3 months 1 year 2 years 5 years
Information/inclusion X
Clinical evaluation x x x x X
Randomisation X
PROMS 
HAGOS X X X X X 
HSAS X X X X X 
iHot12 X X X X X 
EQ-5D X X X X X 
VAS X X X X X 
HAGOS, Hip and Groin Outcome Score; HSAS, Hip Sports Activity Scale; iHOT12, short validated version of the International Hip Outcome 
Tool; PROMS, Patient Related Outcome Measures; VAS, Visual Analogue Scale. 
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randomised in blocks of 4–6 envelopes, at the beginning 
of inclusion. All envelopes and the sequence of the blocks 
is blinded to the surgeon. After completion of the regular 
hip arthroscopy procedure, the randomisation envelope 
indicating the subject’s treatment will be opened. Subjects 
will be randomised into one of two groups (group I: 
hip arthroscopy without capsular closure, group II: hip 
arthroscopy combined with capsular closure). In order to 
ensure patient blinding the surgical report will only state 
whether the capsular treatment was in accordance with 
treatment I or treatment II.
blinding
The patients are blinded to the allocation during the 
first 5 years. It will be recorded in the patient file that 
the capsule was treated according to randomisation but 
not whether the capsule was closed or not. As the patients 
have the right to know in which of the two groups he 
or she has been randomised into at any point of time, 
patients requesting this information before the end of the 
5-year study period will be excluded.
surgical procedure
The surgical techniques represented in this study may vary 
due to different portal placement, anchor types and bone 
resection instruments due to the fact that four surgeons 
in four surgical centres participate in this study. Hip 
arthroscopy is usually performed with the patient under 
general anaesthesia. The operative data reported are the 
amount and location of the portals, surgical procedure 
times including traction times, labral and cartilage injury 
assessment, and surgical technique characteristics such as 
anchor type, number of anchors used and depth of rim 
trimming in millimetres. The depth of the reported cam 
resection is measured in millimetres and the extent is 
measured in degrees using the omega angle as described 
by Rego et al.36
As a standard an anterolateral portal and an inferior 
mid-anterior portal are used. An interportal capsulo-
tomy is performed approximately 5–10 mm distally from 
the labrum from the 11:00–14:00 o’clock position for 
the right hip and the 10:00–13:00 o’clock position for 
the left hip. For the capsulotomy an arthroscopic blade 
is used, making capsular closure more precise. Once the 
intra-articular pathologies have been addressed, the hip 
capsule will be closed or left open depending on what the 
patient has been randomised to. If the capsule is to be 
closed, the hip is flexed to approximately 30° while the 
capsule is closed with two to three No. 2 Vicryl sutures 
(Ethicon), using a ‘Quebec City Slider’ knot technique 
as described by MP.37 As Chahla et al18 could not show a 
significant difference in using two or three sutures when 
performing capsular closure, the decision if two or three 
sutures are used, will be made by the surgeon in order to 
achieve complete closure.
All participating surgeons have undergone supervised 
training by MP in the cadaver laboratory to standardise 
their capsular closure technique. In the period between 
cadaver training in September 2016 and the start of 
this study in June 2017 all surgeons have successfully 
performed capsular closure procedures. Video docu-
mentation of each surgeon was approved by the senior 
surgeon (MP). All deviations from the standard surgical 
procedure, such as the need for a T-shaped capsulotomy 
as well as perioperative complications will be reported. If 
a T-shaped capsulotomy was needed during surgery, that 
patient was excluded from the study.
postoperative medications
The standard postoperative medication includes non-ste-
roidal anti-inflammatory drugs (NSAID) and/or parac-
etamol for 2 weeks, and morphine as needed, but may 
vary between centres.
postoperative rehabilitation
All patients will follow a standardised rehabilitation 
programme, which all participating centres prior to this 
study have agreed on. Apart from written training infor-
mation, the patients will receive supervised instructions 
and/or training by experienced physiotherapists on a 
regular basis within the first 12 weeks after surgery. The 
rehabilitation programme is divided into four different 
phases with an estimated time frame for each phase. 
Progression from one phase to the other depends on 
the successful achievement of phase-specific goals. With 
regard to postoperative restrictions the rehabilitation 
focuses on gradual increase of the hip range of motion, 
core and hip stability, postural control, symmetry with 
functional tasks and gait, strength, endurance, agility and 
finally, the implementation of sport-specific tasks. As the 
patients are going to be discharged on the day of surgery, 
rehabilitation will take place in the outpatient clinic or 
local training facilities. Apart from simple exercises to 
avoid deep vein thrombosis, the patients receive the first 
of four rehabilitation manuals by a physiotherapist when 
discharged from the department. To avoid capsulolabral 
adhesions there is an emphasis on early range of motion , 
for example, by using a stationary bike. Caretakers will be 
involved in early passive range of motion  exercises when 
possible. The standardised use of continuous passive 
motion devices is not planned.
The following postoperative restrictions apply for the 
first 2–3 weeks: partial weight bearing the first 2 weeks, no 
external rotation >30° and hyperextension for the first 
3 weeks. Deviations will be recorded (online supplemen-
tary appendix 1).
data security
The main part of the data will be collected from DHAR 
which is approved by the Danish Health Agency. The 
questionnaires 3 months postoperatively will be collected 
by and stored at the research facility at the Division of 
Sports Traumatology, Department of Orthopedics, 
Aarhus University Hospital THG, Denmark. These data 
will be stored under lock and destroyed by the end of this 
study. Follow-up data at 1 year, 2 years and 5 years will be 
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registered in DHAR. Data including standardised X-ray 
measurements will be stored in a database system with 
a password. In general data will be handled according to 
the regulations of the Act on Processing of Personal Data. 
Relevant anonymised patient -level data are available on 
reasonable request from the authors.
statistics
We have estimated a 10-point increase in the HAGOS 
Sport subscale as a minimal clinically relevant difference 
between groups. When the power is set at 0.9 and at an 
alpha value of 5%, the number of patients in each group 
should be 84 (SD=20). To allow for possible dropouts the 
total estimated sample size of patients included in each 
group is n=100.
risks and adverse effects
The only change in this process compared with other 
hip arthroscopy procedures is the closure of the hip 
capsule. This procedure has, to our knowledge, no addi-
tional adverse effects compared with the complications 
described after hip arthroscopy, such as nerve injury, 
infections, deep vein thrombosis, avascular femoral head 
necrosis or hip fracture.38
limitations and strengths of the study
There are some limitations due to the multicentre design 
of the study. Although all four participating surgeons 
routinely perform hip arthroscopy and have trained 
together in a wet lab performing capsular closure on 
cadaver hip specimens, the techniques of treating the 
underlying hip pathology as well as performing the 
capsular closure may differ. Furthermore, postopera-
tive rehabilitation will be organised and executed in the 
local communities around the four participating hospi-
tals. Although a study group including physicians and 
physiotherapists has implemented a standard postoper-
ative regime, there might be individual, logistical and 
regional differences in how postoperative rehabilitation 
will be carried out. However, these differences in surgical 
technique and postoperative rehabilitation reflect the 
general challenges when comparing clinical results after 
hip arthroscopy, and they are principally eliminated by 
the randomised design. The major strength of this study 
is that the data provided in this randomised controlled 
trial represent the majority of all patients undergoing hip 
arthroscopy for FAIS in Denmark, due to its multicentre 
design and the high volume of patients at the partici-
pating centres.
dIsCussIon
During the past years the number of hip arthroscopies 
has increased rapidly and is now a standard procedure 
in treating intra-articular hip pathologies not related to 
osteoarthritis or developmental abnormalities such as 
hip dysplasia or acetabular retroversion. Due to a more 
precise decision making and a better understanding of 
the biomechanics of the hip joint, outcome of hip arthros-
copy shows promising results. However, the influence of 
(micro)instability on the outcome following hip arthros-
copy has been a topic of interest in recent years. The 
question of whether the hip capsule should be closed in 
every hip arthroscopy or if this decision should be made 
depending on the patient’s biomechanical precondi-
tions, has not been answered yet. The results of this multi-
centre, randomised trial will hopefully lead to a better 
understanding of the role of capsular closure after hip 
arthroscopy for the short-term and long-term outcomes.
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